Skip to content

Clinical trials

Phase 3 Macular Degeneration trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Country / region: Argentina Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20151
20171
20191
20201
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ophthotech Corporation2
4D Molecular Therapeutics1
Allergan1
Astellas Pharma Global Development, Inc.1
Bayer1
IVERIC bio, Inc.1
Laboratorio Elea Phoenix S.A.1
Novartis Pharmaceuticals1
Opthea Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration10
Choroidal Neovascularization3
Eye Diseases3
Geographic Atrophy3
Retinal Diseases3
Wet Macular Degeneration3
Retinal Degeneration2
Vision Disorders2
Blindness1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.